Identification and characterization of OmpL as a potential vaccine candidate for immune-protection against salmonellosis in mice

Vaccine

Volumn 31, Issue 28, 2013, Pages 2930-2936

  Yang, Youjun ^a   Wan, Cuixiang ^b   Xu, Hengyi ^a   Wei, Hua ^a  

^a NANCHANG UNIVERSITY   (China)

^b Sino German Joint Research Institute   (China)

Author keywords

OmpL; Salmonella; Salmonellosis; Vaccine

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; OUTER MEMBRANE PORIN L; PORIN; RECOMBINANT PROTEIN; SALMONELLOSIS VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERICIDAL ACTIVITY; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; PROVOCATION TEST; RETICULOENDOTHELIAL SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALMONELLA PARATYPHI; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SEQUENCE HOMOLOGY; SEROTYPE;

EID: 84884703362     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.04.044     Document Type: Article

References (37)

1. Brenner F.W., Villar R.G., Angulo F.J., Tauxe R., Swaminathan B. Salmonella nomenclature. J Clin Microbiol 2000, 38:2465-2467.
2. Fookes M., Schroeder G.N., Langridge G.C., Blondel C.J., Mammina C., Connor T.R., et al. Salmonella bongori provides insights into the evolution of the salmonellae. PLoS Pathog 2011, 7:e1002191.
3. Kisiela D.I., Chattopadhyay S., Libby S.J., Karlinsey J.E., Fang F.C., Tchesnokova V., et al. Evolution of Salmonella enterica virulence via point mutations in the fimbrial adhesin. PLoS Pathog 2012, 8:e1002733.
4. Crump J.A., Luby S.P., Mintz E.D. The global burden of typhoid fever. Bull World Health Organ 2004, 82:346-353.
5. Majowicz S.E., Musto J., Scallan E., Angulo F.J., Kirk M., O'Brien S.J., et al. The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis 2010, 50:882-889.
6. Crump J.A., Mintz E.D. Global trends in typhoid and paratyphoid fever. Clin Infect Dis 2010, 50:241-246.
7. Santos R.L., Raffatellu M., Bevins C.L., Adams L.G., Tukel C., Tsolis R.M., et al. Life in the inflamed intestine, Salmonella style. Trends Microbiol 2009, 17:498-506.
8. Gordon M.A. Salmonella infections in immunocompromised adults. J Infect 2008, 56:413-422.
9. Graham S.M., Molyneux E.M., Walsh A.L., Cheesbrough J.S., Molyneux M.E., Hart C.A. Nontyphoidal Salmonella infections of children in tropical Africa. Pediatr Infect Dis J 2000, 19:1189-1196.
10. Gordon M.A., Banda H.T., Gondwe M., Gordon S.B., Boeree M.J., Walsh A.L., et al. Non-typhoidal Salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence. AIDS 2002, 16:1633-1641.
11. Chierakul W., Rajanuwong A., Wuthiekanun V., Teerawattanasook N., Gasiprong M., Simpson A., et al. The changing pattern of bloodstream infections associated with the rise in HIV prevalence in northeastern Thailand. Trans R Soc Trop Med Hyg 2004, 98:678-686.
12. Jia K., Thomas C., Akbar M., Sun Q., Adams-Huet B., Gilpin C., et al. Autophagy genes protect against Salmonella Typhimurium infection and mediate insulin signaling-regulated pathogen resistance. Proc Natl Acad Sci U S A 2009, 106:14564-14569.
13. Kantele A., Pakkanen S.H., Siitonen A., Karttunen R., Kantele J.M. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid Salmonella. Vaccine 2012, 30:7238-7245.
14. Mathur R., Oh H., Zhang D., Park S.G., Seo J., Koblansky A., et al. A mouse model of Salmonella typhi infection. Cell 2012, 151:590-602.
15. Gordon M.A., Graham S.M., Walsh A.L., Wilson L., Phiri A., Molyneux E., et al. Epidemics of invasive Salmonella enterica serovar enteritidis and S. enterica serovar Typhimurium infection associated with multidrug resistance among adults and children in Malawi. Clin Infect Dis 2008, 46:963-969.
16. Fraser A., Paul M., Goldberg E., Acosta C.J., Leibovici L. Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials. Vaccine 2007, 25:7848-7857.
17. Guo L., Liu K., Xu G., Li X., Tu J., Tang F., et al. Prophylactic and therapeutic efficacy of the epitope vaccine CTB-UA against Helicobacter pylori infection in a BALB/c mice model. Appl Microbiol Biotechnol 2012, 95:1437-1444.
18. Tobias J., Svennerholm A.M. Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates. Appl Microbiol Biotechnol 2012, 93:2291-2300.
19. Paterson G.K., Maskell D.J. Recent advances in the field of Salmonella Typhi vaccines. Hum Vaccin 2010, 6:379-384.
20. Engels E.A., Falagas M.E., Lau J., Bennish M.L. Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity. BMJ 1998, 316:110-116.
21. Cheminay C., Hensel M. Rational design of Salmonella recombinant vaccines. Int J Med Microbiol 2008, 298:87-98.
22. Li Y., Wang S., Scarpellini G., Gunn B., Xin W., Wanda S.Y., et al. Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA. Proc Natl Acad Sci U S A 2009, 106:593-598.
23. Martin L.B. Vaccines for typhoid fever and other salmonelloses. Curr Opin Infect Dis 2012, 25:489-499.
24. Lee S.J., Liang L., Juarez S., Nanton M.R., Gondwe E.N., Msefula C.L., et al. Identification of a common immune signature in murine and human systemic salmonellosis. Proc Natl Acad Sci U S A 2012, 109:4998-5003.
25. MacLennan C.A., Gilchrist J.J., Gordon M.A., Cunningham A.F., Cobbold M., Goodall M., et al. Dysregulated humoral immunity to nontyphoidal Salmonella in HIV-infected African adults. Science 2010, 328:508-512.
26. MacLennan C.A., Gondwe E.N., Msefula C.L., Kingsley R.A., Thomson N.R., White S.A., et al. The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children. J Clin Invest 2008, 118:1553-1562.
27. Isibasi A., Ortiz V., Vargas M., Paniagua J., Gonzalez C., Moreno J., et al. Protection against Salmonella Typhi infection in mice after immunization with outer membrane proteins isolated from Salmonella Typhi 9,12,d, Vi. Infect Immun 1988, 56:2953-2959.
28. Okamura M., Ueda M., Noda Y., Kuno Y., Kashimoto T., Takehara K., et al. Immunization with outer membrane protein A from Salmonella enterica serovar Enteritidis induces humoral immune response but no protection against homologous challenge in chickens. Poult Sci 2012, 91:2444-2449.
29. Ghosh S., Chakraborty K., Nagaraja T., Basak S., Koley H., Dutta S., et al. An adhesion protein of Salmonella enterica serovar Typhi is required for pathogenesis and potential target for vaccine development. Proc Natl Acad Sci U S A 2011, 108:3348-3353.
30. Hamid N., Jain S.K. Characterization of an outer membrane protein of Salmonella enterica serovar Typhimurium that confers protection against typhoid. Clin Vaccine Immunol 2008, 15:1461-1471.
31. Gil-Cruz C., Bobat S., Marshall J.L., Kingsley R.A., Ross E.A., Henderson I.R., et al. The porin OmpD from nontyphoidal Salmonella is a key target for a protective B1b cell antibody response. Proc Natl Acad Sci U S A 2009, 106:9803-9808.
32. Singh S.P., Singh S.R., Williams Y.U., Jones L., Abdullah T. Antigenic determinants of the OmpC porin from Salmonella Typhimurium. Infect Immun 1995, 63:4600-4605.
33. Thomson D.U., Loneragan G.H., Thornton A.B., Lechtenberg K.F., Emery D.A., Burkhardt D.T., et al. Use of a siderophore receptor and porin proteins-based vaccine to control the burden of Escherichia coli O157:H7 in feedlot cattle. Foodborne Pathog Dis 2009, 6:871-877.
34. Freeman T.C., Landry S.J., Wimley W.C. The prediction and characterization of YshA, an unknown outer-membrane protein from Salmonella Typhimurium. Biochim Biophys Acta 2011, 1808:287-297.
35. Kelley L.A., Sternberg M.J. Protein structure prediction on the web: a case study using the Phyre server. Nat Protoc 2009, 4:363-371.
36. Strindelius L., Degling Wikingsson L., Sjoholm I. Extracellular antigens from Salmonella enteritidis induce effective immune response in mice after oral vaccination. Infect Immun 2002, 70:1434-1442.
37. Feasey N.A., Archer B.N., Heyderman R.S., Sooka A., Dennis B., Gordon M.A., et al. Typhoid fever and invasive nontyphoid salmonellosis, Malawi and South Africa. Emerg Infect Dis 2010, 16:1448-1451.